Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
4
×
indiana top stories
national
national blog main
4
×
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
drug price
jim greenwood
life sciences
merck
regeneron pharmaceuticals
abeona therapeutics
affordable care act
agios pharmaceuticals
alirocuma
alzheimer's
ameet nathwani
arches
biotech
What
industry
4
×
bio
policy
roundup
scalps
american
based
best
continue
crash
debate
healthcare
kind
nash
people
pharmaceutical
politicians
pressure
trump’s
u.s
administration
angry
anti
benefited
biopharma
car
celgene
colleagues
despite
drug
exome
fear
government
health
hundreds
losing
medicine
pharma
plans
presidential
Language
Current search:
industry
×
" national blog main "
×
" indiana blog main "
×
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More